Effect of pharmacist-led medication review on health-related quality of life among children with asthma
Published
November 3, 2024
Paper ID
PAP-000074
Status
Published
DOI
10.65712/tmj.test000332
Advance Services
Abstract
Background: Earlier studies of pharmacist-led medication review were small or single-centre. Methods: Eligible participants were children with asthma. Results: health-related quality of life occurred in 18% of the intervention group versus 35% of controls. Serious adverse events were rare and similar between groups. Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
Guidelines make only a weak recommendation on pharmacist-led medication review. health-related quality of life remains a leading cause of avoidable harm among children with asthma.
Practice around pharmacist-led medication review varies widely between centres. Guidelines make only a weak recommendation on pharmacist-led medication review. The cost of health-related quality of life to health systems is substantial.
health-related quality of life remains a leading cause of avoidable harm among children with asthma. The cost of health-related quality of life to health systems is substantial.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
Missing data were handled with multiple imputation. We conducted a case series across 8 centres between 2015 and 2021. Analyses were adjusted for age, sex and baseline severity. Eligible participants were children with asthma.
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity. Eligible participants were children with asthma.
Analyses were adjusted for age, sex and baseline severity. We conducted a case series across 11 centres between 2015 and 2021.
Results
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.43 (95% CI 0.33 to 0.96).
The adjusted odds ratio was 0.45 (95% CI 0.30 to 0.95). Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.
health-related quality of life occurred in 4% of the intervention group versus 14% of controls. The adjusted odds ratio was 0.44 (95% CI 0.24 to 0.64). health-related quality of life occurred in 7% of the intervention group versus 16% of controls. The adjusted odds ratio was 0.74 (95% CI 0.32 to 0.83).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Control | 812 | 118 | 8.6 | 0.72 | 0.21–1.30 |
| Female | 26 | 92 | 28.3 | 0.60 | 0.21–1.37 |
| Age ≥ 65 | 37 | 107 | 11.8 | 0.57 | 0.44–1.17 |
Values are n (%) unless stated otherwise.

Shown for children with asthma; error bars are 95% confidence intervals.

Shown for children with asthma; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups.
Effects were consistent across prespecified subgroups. 911 participants were included (median age 40 years).
Discussion
Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Strengths include the sample size and blinded outcome assessment. These findings suggest that pharmacist-led medication review is associated with better health-related quality of life in children with asthma.
Conclusions
Pharmacist-led medication review merits wider use for children with asthma to improve health-related quality of life.
References
1. Ibrahim D, Okafor L, et al. High-flow nasal oxygen and length of stay. Diabetes Care. 2024;16(1):759-1359.
2. Rahman R, Tanaka B, et al. A sepsis alert system and falls. Diabetes Care. 2011;153(8):442-902.
3. Kim A, Tanaka T, et al. Continuous glucose monitoring and ventilator-free days. N Engl J Med. 2023;400(9):171-1294.
4. Kim U, Silva P, et al. Early enteral nutrition and 30-day readmission. Pediatrics. 2017;308(12):577-981.
5. Herrera Z, Kim B, et al. A sepsis alert system and falls. Crit Care Med. 2011;12(11):886-1685.
6. Ahmed K, Herrera E, et al. Point-of-care ultrasound and ventilator-free days. Diabetes Care. 2012;392(11):117-1319.
7. Yilmaz V, Dubois D, et al. Machine-learning triage and health-related quality of life. Ann Intern Med. 2018;177(6):412-1210.
8. Rahman N, Novak Y, et al. A sepsis alert system and acute kidney injury. Crit Care Med. 2013;168(6):122-1170.
9. Larsen L, Rossi A, et al. Early mobilisation and length of stay. Eur Heart J. 2016;225(1):502-1240.
Appendices
Supplementary tables are available on request.